<DOC>
	<DOC>NCT00487136</DOC>
	<brief_summary>This is a multiple-dose, double-blind, randomized, single-center, parallel-group study in adult male subjects in general good health.</brief_summary>
	<brief_title>Interaction Between ABT-335, Rosuvastatin and Warfarin</brief_title>
	<detailed_description />
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Fenofibric acid</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Body mass index (BMI) is 19 to 29, inclusive. A condition of general good health, based upon the results of a medical history, physical examination, vital signs, laboratory profile and a 12lead electrocardiogram (ECG). Written informed consent prior to the initiation of screening or studyspecific procedures. Subjects with unstable medical conditions or medical conditions considered inappropriate in a clinical trial. Subjects taking concomitant medications. Subjects with a recent history of surgery or trauma. Subjects with a history of any bleeding disorder.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Drug Interaction</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
</DOC>